(Q34106948)

31 July 2017

1 reference

title

New approaches to topical therapy (English)

1 reference

31 July 2017

Smith CH

1

1 reference

31 July 2017

publication date

1 October 2000

1 reference

Clinical and Experimental Dermatology

31 July 2017

published in

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

567-574

1 reference

Topical corticosteroid phobia in patients with atopic eczema

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Therapeutic strategies for allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Frequency of application of topical corticosteroids: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

A pilot study examining the role of zileuton in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Novel immunomodulators for topical skin disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

The mechanism of action of cyclosporin A and FK506

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Tacrolimus: the drug for the turn of the millennium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00706.X

10.1046/J.1365-2230.2000.00706.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference